Ultra-cheap Ozempic is coming. That’s a mixed blessing for Australians

In late 2029 and 2031, patents for Ozempic will expire in Australia, drastically reducing costs for the weight-loss drug. Over half a million Australians currently on weight-loss medications may soon benefit, as generics from countries like India offer significantly lower prices. The implications could be profound, affecting marriage dynamics and the weight-loss industry worldwide.

Read full article on Brisbane Times →

Summary by Glance · Original reporting by Brisbane Times